Recent research have focused on the overlap of GLP|GIP|glucagon receptor activator therapies and dopaminergic communication. While GLP agonists are commonly employed for addressing type 2 T2DM, their potential effects on reward circuits, specifically mediated by DA systems, are receiving significant attention. This paper presents a summary asses… Read More